Keyphrases
Graft-versus-host Disease (GvHD)
100%
Donor Lymphocyte Infusion
100%
Lymphocyte Infusion
100%
Delayed Transfer
100%
Natural Killer Cells
50%
Graft-versus-leukemia Effect
50%
T Cells
33%
NKT Cells
33%
Regulatory T Cells
33%
Hematopoietic Cell Transplantation
33%
Anti-leukemia
33%
Immune Response
16%
Genetic Modification
16%
Immune Cells
16%
Between-host
16%
Leukemia
16%
Effector Cells
16%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Transplantation
16%
Activity Time
16%
Tissue Specificity
16%
Long-term Efficacy
16%
Donor T Cell
16%
Disease Incidence
16%
Host Tropism
16%
Reduced Graft
16%
Alloreactive
16%
CMV Reactivation
16%
Sustainable Activities
16%
Medicine and Dentistry
Donor Lymphocyte Infusion
100%
Graft Versus Host Reaction
100%
Lymphocyte
100%
T Cell
50%
Hematopoietic Cell
50%
Graft Versus Leukemia Effect
50%
Cell Transplantation
50%
Natural Killer Cell
50%
Regulatory T Cell
33%
Natural Killer T Cell
33%
Infusion
16%
Immunocompetent Cell
16%
Immune Response
16%
Morbidity
16%
Infection
16%
Effector Cell
16%
Tissue Specificity
16%
Leukemia
16%
Biochemistry, Genetics and Molecular Biology
Host
100%
Lymphocyte
100%
Cell Transplantation
60%
T Cell
60%
Natural Killer Cell
60%
Hematopoietic Cell
60%
Regulatory T Cell
40%
Natural Killer T Cell
40%
Immune Response
20%
Immunocompetent Cell
20%
Morbidity
20%
DNA Modification
20%
Tissue Specificity
20%
Immunology and Microbiology
Graft-Versus-Host Disease
100%
Lymphocyte
100%
Natural Killer Cell
50%
Cell Transplantation
50%
T Cell
50%
Hematopoietic Cell
50%
Regulatory T Cell
33%
Natural Killer T Cell
33%
Effector Cell
16%
Immune Response
16%
Immunocompetent Cell
16%
Morbidity
16%
DNA Modification
16%
Tissue Specificity
16%